This is the authors' abstract. We don't add key points for this paper.
Since a previous review (Kellam, 1987), the subject of neuroleptic malignant syndrome (NMS) has continued to cause considerable interest, particularly in the USA where there is still controversy about its frequency, despite two attempts to survey prospectively all cases admitted to two different hospitals. Cases of NMS are now being more widely recognised by non-psychiatrists, especially geriatricians.
Answers are grounded in this paper and cite their sources.
Neuroleptic malignant syndrome is increasingly recognized by non-psychiatrists, though its true frequency remains controversial.
No takes yet. Share an insight, caveat, or question.
A.M.P. Kellam (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: